StockData
Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc. (AGIO) stock

AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/305% above fair value
$28.76−0.92 (-3.10%)

Close on Nov 19, 2026Market cap $1.72BP/E –Yield –

Agios Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Agios Pharmaceuticals's market cap was $1.96B on Nov 11, 2026, against $1.70B a year earlier. Over the last 5 years it ranged from $1.07B to $3.39B, with a median of $1.70B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.96B+23.3%
2025Dec 31, 2025$1.59B-15.3%
2024Dec 31, 2024$1.87B+50.6%
2023Dec 29, 2023$1.24B-19.3%
2022Dec 30, 2022$1.54B-14.3%
2021Dec 31, 2021$1.80B-40.0%
2020Dec 31, 2020$3.00B+6.6%
2019Dec 31, 2019$2.81B+4.8%
2018Dec 31, 2018$2.68B-3.5%
2017Dec 29, 2017$2.78B+58.5%
2016Dec 30, 2016$1.75B-28.2%
2015Dec 31, 2015$2.44B-37.1%
2014Dec 31, 2014$3.88B+421.5%
2013Dec 31, 2013$744.23M–

More Agios Pharmaceuticals figures

See a number that looks wrong?